Ions stock news today
Get breaking news and analysis on Ionis Pharmaceuticals, Inc. (IONS) stock, price quote and chart, trading and SA News•Today, 4:31 PM•3 Comments. Real time Ionis Pharmaceuticals (IONS) stock price quote, stock graph, news & analysis. Here's Why Akcea Therapeutics Jumped 30% Today. Brian Orelli Prev Close 50.07, 52 Wk Low 39.32. Open 52.79, 52 Wk High 86.58. Day Low 49.88, Volume 924,523.00. Day High 53.19, Avg 10D Vol 1.0M Find the latest news headlines from Ionis Pharmaceuticals, Inc. Common Stock ( IONS) at Nasdaq.com.
Ionis Pharmaceuticals, Inc. (IONS) latest earnings report: revenue, EPS, surprise, history, news and analysis.
Stock analysis for Ionis Pharmaceuticals Inc (IONS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. IONS: Message Board for Ionis Pharmaceuticals, Inc ... Ionis Pharmaceuticals, Inc. Message board - Online Community of active, educated investors researching and discussing Ionis Pharmaceuticals, Inc. Stocks. ION Geophysical Corporation - TheStreet Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. Why Ion Geophysical Corp (IO) Is Tumbling on Wednesday ION Geophysical Corporation Ionis Pharmaceuticals Stock Quote: IONS Stock News, Quotes ... Nov 08, 2019 · IONS, Ionis Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Ionis Pharmaceuticals Stock Quote: IONS Stock News, Quotes, Analysis | Investors.com
Ionis Pharmaceuticals Inc. (IONS) Stock Message Board ...
Ionis Pharmaceuticals, Inc., through its drug discovery platform based on antisense technology, discovers and develops drugs that bind to RNA antisense technology.The company has commercialized its antisense drug and has 19 drugs in development. Ionis' drug development programs are focused on treating cardiovascular, metabolic, and severe neurodegenerative diseases and cancer.
IONS: Get the latest Ionis Pharmaceuticals stock price and detailed information including IONS news, historical charts and realtime prices.
Find the latest Ionis Pharmaceuticals, Inc. (IONS) stock quote, history, news and other vital information to help you with your stock trading and investing. Ionis Pharmaceuticals, Inc. Common Stock (IONS) Stock ... Ionis Pharmaceuticals, Inc. Common Stock (IONS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Industry News and Events. IONS Stock Price, Forecast & News (Ionis Pharmaceuticals) Analyzing Ionis Pharmaceuticals (NASDAQ:IONS) stock? View IONS's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. News headlines about IONS stock have trended very negative this week, according to InfoTrie Sentiment. What is Ionis Pharmaceuticals' stock price today? IO Stock Price | ION Geophysical Corp. Stock Quote (U.S ...
IONS: Get the latest Ionis Pharmaceuticals stock price and detailed information including IONS news, historical charts and realtime prices.
Apr 03, 2020 · Akcea Therapeutics, Inc. (AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc. (IONS), today announced that Lisa Johnson-Pratt, M.D., has joined the company as senior vice president of new product strategy. We welcome Dr. Johnson-Pratt and Mr. Patterson to … IO Stock | ION GEOPHYSICAL Stock Price Today | Markets Insider
IO: Get the latest ION Geophysical stock price and detailed information including IO news, historical charts and realtime prices. Ionis Pharmaceuticals Inc. - NASDAQ:IONS - Stock Quote ... Prepare for Biotech Action Aplenty Today. As we await the jobs report, there is significant news across the biotech sector in the past 24 hours on some names I have mentioned in these pages. IONS -- Is Its Stock Price A Worthy Investment? Learn More. IONS Stock Summary. Price to trailing twelve month operating cash flow for IONS is currently 47.63, higher than 92.98% of US stocks with positive operating cash flow. With a price/sales ratio of 10.63, Ionis Pharmaceuticals Inc has a higher such ratio than 88.93% of stocks in our set.